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Available online 22 June 2016Syncytialization process is associated with a reduction in the number of caveolas, and a decreased of caveolin-1
(Cav-1). Differentiation of syncytiotrophoblast affects the membranes phospholipid composition. Thus,
disturbances in these processes are related to pathological conditions such as preeclampsia.
Objective: To analyse the lipid composition of the apical (MVM) and the basal (BM) membranes of
syncytiotrophoblast and its relationship with Cav-1 expression in normal and preeclamptic placentas. Molecular
expression of Cav-1 was determined inMVMand BM fromnormal and preeclamptic placentas and in detergent-
resistant membranes (DRMs). Phospholipids were analyzed by thin layer chromatography. Cholesterol was also
determined by enzymatic assay. Membrane fluidity was evaluated by electron paramagnetic resonance.
Sphingomyelin (SM) molecular species were analyzed and quantified by gas-liquid chromatography and mass
spectrometry.
Cav-1was significantly reduced inMVM frompreeclamptic placentas. Regarding Cav-1 localization, it was barely
detectable in syncytiotrophoblast but itwas present in the endothelium.Western blots also showed a significant-
ly decrease of Cav-1 in the apical DRMs from preeclamptic placentas. Lipid analysis showed an increase SM in
MVM from preeclamptic placentas without changes in cholesterol. Preeclamptic MVM fluidity decreased signif-
icantly and we found an increase in C18:1 fatty acids of SM.
We concluded that preeclamptic-MVMs are more rigid than normal ones, possible due to an increment on SM.
Moreover, the increase of long and unsaturated SMmolecular specie found in these vesicles may disrupt the ability
of SM to assemble into lipid rafts in the luminal leaflet of the bilayer, creating anunfavorable environment for Cav-1.
© 2016 Elsevier B.V. All rights reserved.Keywords:
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Differentiation of human trophoblast cells involves a process that
culminates in the formation of terminally multinucleated
syncytiotrophoblast cells. Resulting from the fusionwith the underlying
cytotrophoblast cells, it forms a polarized syncytium with its apical; BM, basal membrane; STBMs,
ho, cholesterol; Cav, caveolina;
ss spectrometry; PC, phosphati-
sitol; PE, phosphatidylethanol-
y Molecular, Departamento de
, Universidad de Buenos Aires,
.brush border membrane (MVM) facing the maternal circulation and
the smooth basalmembrane (BM) facing the fetal circulation. Although,
the mechanisms controlling syncytiotrophoblast formation are unde-
fined, it is well established that the fusion of cytotrophoblast is essential
for the maintenance of a successful pregnancy [1].
Emerging evidence shows that differentiation of syncytiotrophoblast
affects the phospholipid composition of plasma membrane. It was
found that the composition, structure and functions of these membrane
lipid bilayers are modified with gestational progress in order to meet
themetabolic needs of the growing fetus [2,3]. In addition, in pathological
conditions such as preeclampsia, some authors have found alterations in
membrane lipid composition of syncytiotrophoblast [4,5] and an abnor-
mal expression of transport proteins [6–9] impairing placental functions.
Lipids are the principal components of biological membranes and
play essential roles in cellular function regulating important processes
such as proliferation, apoptosis, metabolism and cell migration [10].
Table 1
Clinical characteristics of severe preeclamptic and normotensive woman. Preeclamptic
was defined as systolic blood pressure ≥ 160 mm Hg and/or diastolic pressure ≥ 110 mm
Hg, with proteinuria ≥0.3 g/day.
Data are the means ± SD. Student's t-test was performed on the data.
Term Control Severe Preeclampsia
Number of pregnant women 32 30
Maternal age, yr 25.1 ± 4.3 26.3 ± 5.2
Gestational age, wks from LMP 38.8 ± 1.7 35.7 ± 2.6
Body Mass index (BM), kg/m2 25 ± 3 24 ± 4
Proteinuria Negative +++
Mean blood pressure, mm Hg
Systolic 111.0 ± 3.2⁎ 160.3 ± 3.5⁎
Diastolic 63.9 ± 2.1⁎⁎ 113.0 ± 2.3⁎⁎
Birth weight, g 3290 ± 513 2630 ± 1081
Values are means ± standard deviation.
LMP: last menstrual period.
⁎ P b 0.01.
⁎⁎ P b 0.01.
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the progression of several diseases [11,12].
Recently, Korkes and co-workers demonstrated that lipids found in
plasma and placental tissue from pregnant women with preeclampsia,
differ from those expressed in healthy pregnancies [4]. In addition,
other authors reported that syncytiotrophoblast microvesicles
(STBMs) from preeclamptic women have a different pattern and
distinct concentrations of some lipid species compared to STBMs from
control group [5]. However, up to now, it is unknown if these changes
are related to the pathogenesis of preeclampsia.
It iswell-established that sphingomyelin (SM) and cholesterol (Cho)
constitute various types ofmicrodomains in plasmamembranes such as
caveolas [12]. Caveolas are plasma membrane invaginations,
50–100 nm in diameter, important in endocytosis, lipid trafficking,
and signal transduction [13,14]. Originally discovered in the
endothelium [15], caveolas have now been identified in many cell
types including epithelium, adipocytes, fibroblasts, and smooth,
skeletal, and cardiac muscle cells. Caveolin proteins are the major
structural component of caveolas. Three caveolin isoforms have been
described in mammalian cells: caveolin-1 (Cav-1), caveolin-2 (Cav-2),
and caveolin-3 (Cav-3). Cav-1 and Cav-2 are co-expressed in most cell
types and are required for the formation of caveolas, while Cav-3 is a
muscle-specific protein, predominantly expressed in skeletal and
cardiacmuscle [16]. Caveolins have been implicated in the pathogenesis
of various organ injuries and in conditions such as ischemia, in which a
mismatch occurs between energy production and utilization. Such con-
ditions are associated with altered expression of caveolas or redistribu-
tion of caveolin; for instance, hypoxic injury imposed on renal proximal
tubules causes Cav-1 release, accompanied with caveolas disruption,
and Cav-1 appearing within the extracellular space was largely in the
denatured form [17].
In human placenta, Cav-1 is strongly expressed in endothelial cells,
with lower levels in cytotrophoblasts, mesenchymal cells, and
syncytiotrophoblast [18–21].
Unlike the situation reported for other differentiated cells,
syncytialization process was associated with a mark reduction in the
number of caveolas, and a decreased expression of Cav-1 [22]. Although
the reduction in Cav-1 as trophoblasts syncytialise may simply be a
feature of the loss of lateral cell membranes following cell fusion, it is
unknownwhether disturbances in this processmay alter the expression
in Cav-1.
Recently, Smith-Jackson and coworkers have described a decreased
expression of Cav-1 in preeclamptic placentas [23]. However, whether
changes in the membrane lipid composition of syncytiotrophoblast
may affect the expression of Cav-1 was not investigated.
In the present work, we examined the lipid composition of the
apical and the basal membranes of syncytiotrophoblast and its
relationship with the expression of Cav-1 in normal and preeclamptic
placentas.2. Materials and methods
2.1. Tissue collection
This study was approved by the local ethics committees of the
“Hospital Nacional Dr. Prof. Alejandro Posadas”, Buenos Aires,
Argentina, and written consent was obtained from patients before the
collection of samples.
Full-term normal (n = 32) and severe preeclamptic (n = 30)
placental tissues were obtained after cesarean section (Table 1).
Severe preeclampsia was defined as systolic blood
pressure ≥ 170mmHgand/or diastolic pressure ≥ 110mmHg,with pro-
teinuria ≥0.3 g/d or 2 pluses onurinedipstick after the 20thweek of ges-
tation in a previously normotensive patient. The preeclamptic women
were identified as late-onset of preeclampsia.2.2. RT-PCR Assay
Several placental cotyledonswere removed from underlying fibrous
elements and rinsed thoroughly in 0.9% NaCl at 4 °C. Soft villous materi-
al from thematernal surface enriched in trophoblast cells was cut away
from connective tissue and vessels until approximately 1 gwere collect-
ed. The tissue was rinsed again in order to remove most of the blood
cells and then homogenized on ice for 30 s by using an Ultra-Turrax
T25 blender at maximum speed. Total RNA from trophoblast cells was
isolated by using an SV Total RNA isolation system (Promega Co.,
USA). Reverse transcription was performed for 60 min on 5 μg of total
RNA by using moloney murine leukemia virus reverse transcriptase,
oligo (dT)15 primer and 400 μM of each deoxyribonucleotide triphos-
phate (dNTP) at 42 °C. PCR (30 cycles) at 94 °C for 60 s, at 58 °C for
60 s and at 72 °C for 60 s, followed by a final extension of 10 min at
72 °C, was carried out by using 5 μM of a specific oligonucleotide
primers for human Cav-1. These primers amplified a 434-bp region of
human Cav-1 including nucleotides 313 through 747 (sense 5′-TCTC
TACACCGTTCCCATCC-3′ and antisense 5′-CACAGACGGTGTGGACGT
AG-3′). These primers were designed using http://www-genome.wi.
mit.edu/cgi-bin/primer/primer3_www.cgi on the bases of Gene Bank
sequences (accession number: NM_001753).
Control experiments were performed without the addition of re-
verse transcriptase to evaluate the absence of genomic DNA
amplification.2.3. Apical (MVM) and basal (BM) membrane vesicles isolation
Human placenta villi from normal term and preeclamptic placentas
were processed according to the method previously described [24].
Briefly, human chorionic villi were fragmented, and washed with
unbuffered 150 mM NaCl. The tissue was then shaken for 1 h with 1.5
volumes of HES buffer (10 mM HEPES-KOH, 0.1 mM EGTA, 250 mM
sucrose) pH 7.4, with protease inhibitors (0.2 mM PMSF, 25 μg/mL
p-aminobenzamidine, 20 μg/mL aprotinin, 10 μg/mL leupeptin,
10 μg/mL pepstatin), followed by filtration and centrifugation at
3100 g for 10 min. The supernatant was then further centrifuged
10 min at 11,000 g and the resulting supernatant centrifuged 70 min
at 16,000 g.
The pellet was then resuspended in HES buffer containing 10 mM
MgCl2 to selectively precipitate non-apical membranes. The suspension
was then incubated 10 min with constant stirring, after which it was
centrifuged 30 min at 5000 g. The basal membrane-enriched pellet
was redissolved in HES buffer containing protease inhibitors, and stored
at−80 °C. Finally, the supernatant was centrifuged 70 min at 16,000 g
and the apical membrane-enriched pellet was resuspended in HES
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assayed for biochemical markers. Alkaline phosphatase and adenylate
cyclase activities (as markers for MVM and BM, respectively) were
determined in the eachmembrane suspension. Enrichment of themem-
branes isolated was b20-fold for MVM and b11-fold for BM).
2.4. Western blot
For immunoblotting studies, 10–20 μg of membrane fraction
proteins was dissolved in Laemmli loading buffer (4% sodium dodecyl
sulphate, 0.125 M Tris-HCl pH 6.8, 0.2 M dithiothreitol, 0.02%
bromophenol blue, 20% glycerol), heated to 90 °C for 2 min, resolved
on 15% polyacrylamide gel and electrotransferred onto nitrocellulose
membranes (Hybond ECL, Amersham Pharmacia Biotech Ltd., UK).
Membranes were blocked with 1 (w/v) bovine serum albumin in TBS
at room temperature for 30 min and incubated overnight with a rabbit
polyclonal primary antibody (Santa Cruz Biotechnology Inc., USA)
against human Cav-1 diluted 1:1000. Membranes were washed with
TBS-Tween 0.1%, and then with a goat anti-rabbit immunoglobulin G
([IgG] Jackson ImmunoResearch Laboratories, Inc. West Grove, PA,
USA; 1:10,000) conjugated to peroxidase. Immunoreactivity was
detected using the Enhanced Chemiluminescence (ECL) Western
Blotting Analysis System (ECL plus, Amersham Pharmacia Biotech Ltd.,
Pittsburgh, PA USA) according to the manufacturer's instructions.
The densitometry of the bands was quantified by the ImageJ 1.45s
software package (Bethesda, MD, USA).
To confirm equal loading, each membrane was stripped and
analyzed for β-actin protein expression, demonstrating that the band
intensities did not present significant changes between the samples
studied.
2.5. Immunohistochemistry
Human villous tissue from normal and preeclamptic placentas were
cut into small pieces, fixed overnight in 10% formaldehyde - 0.1M sodi-
um phosphate buffer (PBS), pH 7.4, dehydrated, and embedded in par-
affin. Paraffin sections (4 μm) were cut and mounted on 2% silanized
slices, dried, dewaxed and rehydrated. Tissue slices were incubated in
3% H2O2/methanol for 5 min to block endogenous peroxidase, and
washed three times in 10 mM PBS, pH 7.4, for 5 min. All subsequent
steps were carried out in a humidified chamber. Non-specific binding
sites were blocked by incubation at room temperature in blocking re-
agent (DAKO LSAB kit, Dako Corp., USA) for 30min. Sectionswere incu-
bated overnight with anti Cav-1 antibody at a dilution of 1:50. Sections
were then washed with 0.05 M PBS for 5 min, incubated for 10 min in
prediluted link antibody, washed again in PBS buffer and incubated for
30min in a solution of streptavidin-conjugated horse-radish peroxidase
in PBS. Color development of the antibody labeling was achieved under
microscopic control by incubating slices with the substrate DAB/NiCl2
(3,3′-diaminobenzidine/nickel chloride) and 0.3% hydrogen peroxide
in distilled water. Counterstain by hematoxylin was performed.
Non-immune mouse serum without primary antibody was used as a
negative control.
2.6. Isolation of detergent-resistant membranes (DRMs) by sucrose
gradient centrifugation
DRMswere prepared fromMVMand BMvesicles obtained frompre-
eclamptic and normal human placental syncytiotrophoblast following a
previously detailed protocol [25] introducing minor modifications.
Briefly, 1.5 mg of protein of each membranes were incubated at 4 °C
during 30 min with TNE buffer (10 mM Tris, 200 mM NaCl, 1 mM
EDTA, pH 7.4) containing Triton X-100, so that the final volume was
1 mL and the final detergent concentration 16 mM. Samples were dis-
persed by 10 passages through a 21-gauge needle. After incubation,
the lysate was diluted with an equal volume of 80% (v/v) sucrosesolution in TNE buffer containing 0.3 M Na2CO3. One milliliter of this
suspension was overlayered by 2.3 mL of 35% sucrose, followed by
1 ml of a 5% sucrose, both solution prepared in TNE buffer. The samples
were centrifuged at 190,000 g in a Beckman SW60 Ti rotor at 4 °C for
18 h. After ultracentrifugation, one fraction of 0.33mL and four fractions
of 1 mL were collected from the top of the tube and saved for
subsequent characterization. All fractions were stored frozen at 20 °C
for further analysis.
2.7. Protein detection in sucrose density gradient fractions
Sucrose gradient fractions of MVM and BM of syncytiotrophoblast
from preeclamptic and normal placentas were subjected to SDS–PAGE
5%–20% (w/v) gradient polyacrylamide gels for Western blot analysis.
Prior to perform the electrophoresis, fractions were dialysed against
TNE buffer overnight so as to eliminate sucrose. Then samples were
concentrated to dryness by speed-vac. Finally, the precipitated were
diluted in 30 μL of SDS-PAGE loading buffer.
After proteins were separated by SDS-PAGE 5–20%, gels were trans-
ferred to nitrocellulose membrane. After blocking blots were incubated
with a solution containing a polyclonal anti-Cav-1 (Santa Cruz Biotech-
nology, Inc.; 1:1000) and revealed as we have described.
2.8. Lipid analysis
2.8.1. Major lipid classes
Total lipids from the purified MVM and BM vesicles were extracted
according to the method of Bligh and Dyer [26]. Total phospholipid
amount was determined by the method of Fiske and Subarrow [27]
and Cholesterol content was measured by an enzymatic method with
the commercial kit (Colestat®, Wiener Laboratory, Rosario, Argentina).
Individual phospholipids were separated from total lipid extracts by
thin-layer chromatography (TLC) on high-performance TLC plates
(Merck, Darmstadt, Germany) in order to determine and quantified
the major phospholipid classes. The extracts were dissolved in chloro-
form, dried under nitrogen stream and applied to silica gel G precoated
TLC plates (0.25 mm thick) and submitted to two-solvent, one-
dimensional thin-layer chromatography. Solvents I and II were
40:10:10:1 (v/v) and 120:46:19:3 (v/v) chloroform:methanol:acetic
acid:water, respectively. For the quantification of phospholipids,
specific areas of the TLC plates were identified by comparison with
commercial standards, scraped off and digested with 70% perchloric
acid in thepresence of ammoniummolybdate (0.5%), for 2 h in a heating
block at 180 °C. The resulting inorganic phosphate was assayed with a
Fiske–Subbarow reagent [27].
2.8.2. Sphingomyelin species of MVM-vesicles from normal and preeclamp-
tic placentas
Total lipids were extracted using the modified Bligh and Dyer's
method described by Baig et al. [5]. Briefly, 750 μL of ice cold
chloroform:methanol (1:2, v/v)was added toMVM-vesicles resuspend-
ed in 100 μL of PBS. Themixturewas vortexed vigorously for 1min. After
shaking at 200 g at 4 °C for 1 h, 250 μL ice cold chloroform and 350 μL of
ice cold water was added to the samples. The samples were then sub-
jected to another 1min vortexing. The phaseswere separated by centri-
fugation at 11,000 g for 2 min and the lower organic phase containing
the lipids was transferred to a fresh tube. Lipids were re-extracted
from the remaining aqueous phase with 500 μL of ice cold chloroform.
The two extracts were pooled and vacuum-dried. Dried lipid film was
then reconstituted in chloroform: methanol 1:1 (v/v) prior to analysis
by liquid chromatography-mass spectrometry (LC-MS).
Lipid extracts prepared from MVM-vesicles of normal and
preeclamptic placentas were analyzed by LC-MS coupled to a Q-TOF
detector (model micrOTOF Q II, Bruker) in negative mode as described
by [28]. [M-H]-ions were extracted and integrated using the software
Compass Data Analysis from Bruker.
Fig. 1. Placental Cav-1 expression and localization in normal and preeclamptic placentas. A) Semiquantitative RT-PCR of Cav-1 gene expression in normal placenta and preeclamptic
placenta. Densitometry analysis showed no significantly changes between normal and preeclamptic placentas. B) Representative Western blot for Cav-1 in normal and preeclamptic
tissues. Densitometry of immunoblot showed a significantly decreased (*P b 0.05) in preeclamptic-MVM. However, no changes were observed in BM from normal and preeclamptic
placentas. The relative values of Cav-1 were normalized against β-actin. Values are shown as mean ± SEM. Student's t-test was performed on the data, n = 15 in each experimental
group. C) Immunolocalization of Cav-1 in representative sections of placental villous from normal and preeclamptic placentas. Arrows indicate Cav-1 labeling. In normal placentas Cav-
1 was localized in the apical membrane of syncytiotrophoblast (arrows) and in endothelial cells (arrow heads) (panel A). In preeclamptic placentas, although Cav-1 was found in
endothelial cells (arrow heads) and in the basal membrane (arrows) it was almost undetectable in the apical membrane of syncytiotrophoblast (panel B). Negative controls were
performed by omitting the primary antibody and replaced by a non-immune rabbit serum (panel C and D). Magnification: 1000×.
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Fig. 2. Differential distribution of Cav-1 in sucrose gradient fraction of MVM and BM from
normal and preeclamptic placentas. Detergent-resistant microdomains (DRMs) were
isolated on a discontinuous sucrose gradient. In MVM of normal placentas, Cav-1 was
concentrated at fraction 1, but in preeclamptic placentas, it is clearly diminished in
fraction 1 and absent in fraction 2. Regarding BM, Cav-1 was preferentially found in the
bottom of the sucrose gradient (fractions 3, 4 and 5) in both, normal and preeclamptic
placentas.
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A useful method to characterize the degree of order/mobility of the
membrane lipids acyl chains is spin-label electron paramagnetic
resonance (EPR) [29]. Adequate amount of 5-doxylstearic acid 1 mM
was added to an aliquot (0.1 μmol phospholipid) of the vesicles in
Tris–NaCl buffer pH 7.6, to achieve a 1:50 spin/phospholipid molar
ratio. After 10 min incubation at room temperature (20 °C), 85 μL of
potassium ferricyanide (200mg/mL)was added to broaden the external
spin label ESR signal. ESR spectra were recorded at 20 °C using an
X-band ESR Spectrometer Bruker ECS 106 (Brucker Instruments, Inc.,
Berlin, Germany). The spectrometer settings were: center field
3485.00 G, sweep width 100.00 G, microwave power 20.0 mW, modu-
lation frequency 50 KHz, modulation amplitude 0.203 G, conversion
time 40.96 ms, time constant 655.36 ms, resolution 1024 points.
MVM and BM-vesicles order parameters (S) were calculated as
described by Arvidson and co-workers [30]. Briefly, S is given by the
ratio of the spectral anisotropy in the membranes (A|| − A⊥) to the
maximum anisotropy obtained in a rigidly oriented system (defined
by Axx, Ayy, Azz the principal values of the spin label tensor) and was
calculated from the respective ESR spectrum using the following equa-
tions:
S ¼ Ajj−A⊥
 
Azz−0:5 Axx−Ayy
 α00
α0
ð1Þ
The A value was calculated using the following corrections
expression:
A⊥ ¼ A0⊥ þ 1:4
1− Ajj−A
0
⊥
 
Azz−0:5 Axx þ Ayy
 
( )
for Ajj0:45
  ð2Þ
A⊥ ′ and A|| are the actual hyperfine constant values measured from
the ESR spectrum. The polarity corrections term α'0/α0 is calculated by:
α0 ¼
Ajj ¼ 2A⊥
3
ð3Þ
α00 ¼
Axx þ Ayy þ Azz
3
ð4Þ
The S parameter gives a measure of the degree of structural order in
the membrane, with parameters between S = 1 for a rapid spin-label
motion about only one axis and S= 0 for a rapid isotropic motion. An
increase in S parameter represents the consequence of an increase in
the membrane order.
2.10. Statistical analysis
Statistical analysis of data was performed by GraphPad Prism v5
software (GraphPad Software, Inc. La Jolla, CA, USA). Results are given
asmean± S.E.M. Student's t-test was used to evaluate data statistically.
A P-value of b0.05 was considered to be statistically significant.
3. Results
3.1. Expression of Cav-1 in preeclamptic placenta
First, we investigated the expression of Cav-1 at the transcriptional
and protein levels. Total RNA was extracted and RT-PCR analysis was
performed. An expected band of ~434-bp was obtained in normal and
preeclamptic placentas and in both cases the semiquantitative PCR anal-
ysis showed no difference in Cav-1 expression (Fig. 1A). Instead, when
the protein levels of Cav-1 was analyzed in MVM and BM of normal
and preeclamptic term placentas by Western blot, some differences
were found (Fig. 1B). In normal placentas the antibody revealed anexpected band of 22 kDa, in both fraction, MVM and BM. On the other
hand, in preeclamptic placenta Cav-1 was principally found in BM.
Semiquantitative analysis showed that Cav-1 decreased 6.5-fold in
MVM of preeclamptic placentas, but the amount of Cav-1 in BM was
similar compared to normal placenta.
No bandswere observedwhen the primary antibodywas omitted or
when the Cav-1 antibody was preadsorbed with the Cav-1 specific
peptide (data not shown).
In order to corroborate the results found by Western blot, chorionic
villi from normal and preeclamptic placentas were analyzed by immu-
nohistochemistry. In normal placentas Cav-1 was localized in the
MVM of syncytiotrophoblast and in endothelial cells (Fig. 1C, panel A).
Instead, in preeclamptic placentas, although Cav-1 was found in endo-
thelial cells, nevertheless it was almost undetectable in the apical mem-
brane of syncytiotrophoblast (Fig. 1C, panel B). Control sections treated
with non-immune serum showed absence of labeling in normal and
preeclamptic placentas as shown in Fig. 1C, panels C and D, respectively.3.2. Expression of Cav-1 in DRMs
Considering that Cav-1 is localized mainly in membrane microdo-
mains enriched in sphingolipids and cholesterol [13–16] we investigat-
ed the presence of this protein in DRMs fraction of both normal and
preeclamptic placenta. Anyway, it is important to remember that the
terms “membrane microdomains” and “DRMs” should not be used as
synonyms because they have different origins and conceptualmeanings
[25]. However, a very much used approach in the current literature to
investigate the interaction between a protein and membrane microdo-
mains is the DRM technique. This technique takes profit from the selec-
tive solubilization of different lipids occurring when a biomembrane is
submitted to the action of a nonionic detergent such as Triton X-100.
Fig. 2 shows the immunoblot analysis of the fractions obtained by su-
crose gradient ultracentrifugation as described under “Material and
methods.” As expected for polarized cells higher concentration of Cav-
1 seems to be in MVM. In MVM of normal placentas it is distributed in
light sucrose gradient fraction (1,2,3,4 and 5), being more concentrated
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fractions 4 and 5 while it is absent in fraction 2. On the other hand,
Cav-1 is preferentially found in the bottom of the sucrose gradient in
BM of normal and preeclamptic placenta (fractions 3, 4 and 5).3.3. Membrane lipid composition
In order to explain thedifferent localization of Cav-1 in chorionic villi
from preeclamptic placenta compared to normal ones, we analyzed the
lipid composition of MVM and BM-vesicles.Fig. 3. Phospholipid composition of plasma membrane from normal and preeclamptic plac
Phosphatidylcholine (PC), Phosphatidylinositol (PI), Phosphatidylserine (PS), Phosphatidyl
phospholipid class respect to total phospholipids. B) Major phospholipid classes in MVM a
phospholipid class respect to total phospholipids. C) Comparative phospholipid classes of MVM
of BM-vesicles from normal and preeclamptic placentas. Data are expressed as nmoles of each
was performed on the data, n= 20 in each experimental group. (*P b 0.05).3.3.1. Phospolipid composition
The phospholipid composition was evaluated in MVM and
BM-vesicles of human normal placenta. We found that the major
phospholipid class was Phosphatidylcholine (PC) in both, MVM and
BM. The relative amount of Phosphatidylserine (PS), Phosphatidylinositol
(PI), Phosphatidylethanolamine (PE) and Sphingomyelin (SM) were
similar in both membranes (Fig. 3A). Unexpectedly, in MVM of pre-
eclamptic placentas we found that SM was the major phospholipid
class (Fig. 3B).
On the other hand, when we analyzed the MVM phospholipid
composition from preeclamptic placentas, we observed an increase ofentas. A) Major phospholipid classes in MVM and BM-vesicles from normal placentas:
ethanolamine (PE) and Sphingomyelin (SM). Data are expressed as percentage of each
nd BM-vesicles from preeclamptic placentas. Data are expressed as percentage of each
-vesicles from normal and preeclamptic placentas. D) Comparative phospholipid classes
phospholipid class per mg of protein. Values are shown as mean ± SEM. Student's t-test
Fig. 4. Study of SM species in normal and preeclamptic MVM-vesicles by liquid
chromatography-mass spectrometry (LC-MS). A) The major SM molecular species in
both normal and preeclamptic MVM-vesicles. B) The relative increment of each SM
species in MVM preeclamptic placentas over normal ones.
Table 2
Cho/phospholipid and SM/PC molar ratios.
MVM-vesicles from preeclamptic placentas have an increase of SM content compared to normal ones without changes in Cho amount. Thus, we observed a significant increase of SM/PC
ratio compared to normal ones (n= 15; *P b 0.05) and no change in the Cho/phospholipid ratio (n= 27).
No differences were observed either in SM/PC neither Cho/phospholipid ratios between BM-vesicles form normal and preeclamptic placentas.
Cholesterol (nmol/mg of protein) Total phospholipid (nmol/mg of protein) Cho/total phospholipid
MVM normal placenta 308 ± 64 368.8 ± 53.7 0.84
MVM preeclamptic placenta 341 ± 63 411.1 ± 60.8 0.83
BM normal placenta 313 ± 38 430.8 ± 96.3 0.73
BM preeclamptic placenta 270 ± 29 355.2 ± 56.8 0.76
PC (nmol/mg of protein) SM (nmol/mg of protein) SM/PC
MVM normal placenta 124 ± 14 97 ± 14 0.78
MVM preeclamptic placenta 120 ± 16 162 ± 23 1.35⁎
BM normal placenta 138 ± 22 93 ± 17 0.67
BM preeclamptic placenta 152 ± 20 97 ± 15 0.64
⁎ P b 0.05, n= 15.
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However, the relative amount of PE was significantly lower. Regarding
phospholipid composition of BM from preeclamptic placentas, PE and
PSwere significantly decreased compared to normal placentas (Fig. 3D).
3.3.2. Cholesterol (Cho) content
Wedetermined the content of Cho inMVMandBM fromnormal and
preeclamptic placenta.We found no significant differences between BM
and MVM from normal placentas. The same results were obtained for
preeclamptic placentas. No changes were observed in Cho content
when normal and preeclamptic placentas were compared (Table 2).
3.3.3. Fatty acid composition of amide-linked substituents to sphingomyelin
in MVM vesicles obtained from preeclamptic and normal placentas
Since nature of the fatty acid moiety of the SM drastically affects
membrane structure [30], we studied the SM species by LC-MS. Fig. 4A
showedmolecular species of SM ofMVM-vesicles fromnormal and pre-
eclamptic placentas. Mass spectrometry analysis allowed the determi-
nation of the total number of carbon atoms and double bonds in the
fatty acid moiety for lipid classes. In all SM species, C18:1 sphingosine
was the sphingoid base. Themajor SMmolecular species in both normal
and preeclamptic MVM-vesicles was 16:0 SM (42 and 41%, respective-
ly), followed by 18:0 (25 and 19%, respectively). Interestingly, 18:1
SM content increased twenty five fold in MVM-vesicles from
preeclamptic placentas compared to MVM-vesicles from normal ones
(Fig. 4B). This result demonstrates that the increment of total SM ob-
served in MVM from preeclamptic vesicles over normal one (Fig. 3) is
exclusively due to the increment in the 18:1 SM specie.
3.4. Membrane order
SM is, together with Cho, relevant in determining lipid conforma-
tional order and packing [31–33].
As wementioned above, MVM-vesicles from preeclamptic placentas
have an increase of SM content compared to normal ones without
changes in Cho amount. Thus, we only observed a significant increase
of SM/PC ratio compared to normal ones (n = 15; P b 0.05) (Table 2).
Accordingly with SM/PC ratio, the S parameter was significantly higher
in MVM-vesicles from preeclamptic placentas comparing to normal
ones, reflecting an increment reduction in membrane order (Fig. 5A).
No differences were observed either in SM/PC and Cho/total
phospholipid ratios (Table 2) neither in the S parameter between
BM-vesicles form normal and preeclamptic placentas (Fig. 5B).
4. Discussion
Fusion of placental villous cytotrophoblasts with the overlying
syncytiotrophoblast is essential for the maintenance of successful preg-
nancy, and disturbances in this process have been implicated inpathological conditions such as preeclampsia, a pregnancy disorder
characterized by hypertension and proteinuria.
Results obtained in the present study demonstrated that Cav-1
protein expression was barely detectable in the apical membrane of
syncytiotrophoblast from preeclamptic placentas. However, no change
was observed at transcriptional levels. Even more, we observed a
normal expression and localization in the basal membrane and
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brane of syncytiotrophoblast from preeclamptic placentas. Moreover,
the presence of Cav-1 in DRMs of apical membranes of preeclamptic
placentaswas diminished, suggesting a deregulation in caveolas assem-
bly. Caveolin itself is highly enriched in DRMs, indeed it is widely used
as a raft marker, though it likely defines a subset of raft domains in-
volved in caveolin-mediated traffic. Importantly, caveolin only associ-
ates with raft after its oligomerization; process which is stabilized by
raft lipids present in plasma membrane and the late Golgi [34,35].
Specifically, the assembly of caveolas is dependent on the cooperative
action of cavin and caveolin that bends the membrane and stabilizes
the characteristic morphology of caveolas. The importance of Cho bind-
ing to caveolins to form caveolas is also established [36,37]. In addition,
the most abundant negatively charged phospholipids of the plasma
membrane, PS and the phosphoinositide phosphatidylinositol (4.5)-
bisphosphate have been suggested to be concentrated in caveolas,
forming physiologically distinct lipid pools [38–40]. These data suggest
a major role of lipids in the regulation of the biophysical properties of
the lipid bilayers, allowing an adequate formation and stabilization of
caveolas.
On the other hand, it was postulated that the sphingolipid-rich api-
cal domains are originated from sphingolipid- and cholesterol-enriched
microdomains in trans-Golgimembranes [41–43]. Thesewould then act
as a sorting device for the delivery of apically directed cell surface com-
ponents in polarized epithelial cells. Actually, it was reported thatFig. 5. Membrane order by Electron Spin Resonance (ESR). A) Representative ESR spectrum
incubated with 5-doxylstearic acid (1:50 spin:phospholipid molar ratio) for 10 min at 20 °C a
ECS 106. Membrane order was estimated from the spectrum by the order parameter S, usin
inner extremes used in the calculation of the order parameter S. B) S parameter of MVM
Student's t-test was performed on the data, n= 12 in each experimental group. (*P b 0.05).changes in lipid composition such as the replacement of long-chain
SM by short-chain SM, locally prevents the formation of a raft like
liquid-ordered domain in the Golgi membraneswhich, in turn, could af-
fect the generation of transport carriers or their fusionwith targetmem-
branes [44].
Therefore, we analyzed the lipid membrane composition of
normal and preeclamptic syncytiotrophoblast and found a different
pattern of lipids in MVM and BM. Many authors have studied the
phospholipid composition of syncytiotrophoblast cells but
they did not distinguish between both membranes [4,5,45]. As
syncytiotrophoblast is a polarized cell, the contribution of each
phospholipid species is crucial to determine the apical or basal
membrane transport function.
As it was expected, the more abundant phospholipid in normal
membranes was PC, for both MVM and BM-vesicles. Instead, SM was
the major phospholipid in MVM of preeclamptic placentas. Taking into
account that SM/PC ratio determines the lipid order of the membrane
[33], this increment in SM may alter this order. In addition, an increase
in PS content was also observed in MVM from preeclamptic placentas.
These findings correlate with previous results published by Baig et al.
where they also found an increment of SM and PS in vesicles derived
fromMVM of preeclamptic placentas, which are shed into maternal cir-
culation [5]. In total syncytiotrophoblast membranes from preeclamtic
placentas, Huang and coworkers have also observed an increase in
PS + PI content [45].of the 5-doxilstearic acid inserted into the MVM from normal placentas. Vesicles were
nd then, the ESR spectrum was obtain at 20 °C using an X-band ESR Spectrometer Bruker
g the equations written in Materials and methods. A|| and A′⊥ values are the outer and
and BM from preeclamptic and normal placentas. Values are shown as mean ± SEM.
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membranes, MVM and BM, from preeclamptic placentas. As we
previously reported, we proposed that this reduction might be due to
an increment in the arachidonoyl phophatidylethanolamine
phopholipase D, enzyme that synthesizes anandamide by cleavage of
PE from the membrane [46].
Regarding Cho, our data differ from those reported by Powell and co-
workers [47]. They found that Cho content of syncytiotrophoblast-BM
was lower than in MVM. However, our findings showed that Cho does
not change significantly in both membranes. A possible explanation
for these discrepancies could be the differences among the studied pop-
ulations, in particular maternal nutritional status and ethnicity. Even
more, some previous studies have reported that the lipid profile of
human placenta may be modified by maternal nutrition [48].
In addition, we found that Cho content of preeclamptic-MVM was
similar to that of normal placentas, a fact that could explain the
observed normal expression of Cav-1 mRNA, considering that Cho reg-
ulates Cav-1 expression at the transcriptional level [49,50]. Pol et al.
have added a level of complexity on this regulation showing that free
cholesterol also regulates the traffic of newly synthesized protein
through the Golgi complex to the plasma membranes, independent of
caveolin synthesis [34].
It is well-known that the preferential interaction between SM and
Cho in both, cell andmodel membranes, is a key factor in the formation
of Cho- and SM- rich domains in membranes [41,51–52]. Cho and SM
have both hydrogen-bond donor and acceptor groups that together
with the Cho flat and extended hydrophobic structure promote the
tight packing of SM and Cho into the liquid-ordered arrangement [53].
Thus, SM and Cho, are relevant in determining lipid conformational
order and packing [31–33]. In this context, in a previous report we dem-
onstrated that independently of the Cho content, SM/PC ratio deter-
mines the lipid order of the membrane; as the SM/PC ratio increase,
the order of the membrane also increase [33]. In the present paper,
membrane order was determined by EPR in normal and preeclamptic-
MVM vesicles. We found differences, possibly related to the different
SM content found between them, which may be affecting the localiza-
tion of Cav-1 into sucrose fractions.
In agreement with Epand et al. [54], we also previously showed that
when an unsaturated sphingolipid, oleoyl-SM or nervonoyl-SM, is
included in a lipid mixture, no lateral phase separation is detected in
fluid membranes containing Cho and DOPC (dioleylphophatidylcholine)
[33]. Taking into account all these results, we suggest that the increment
of SM, specifically the SM 18:1, in preeclamptic-MVM is directly related
with the increment of the lipid order and the destabilization of caveolae.
In view of all these results, we propose that the altered lipid
composition of preeclamptic MVM-vesicles may compromise cellular
processes that critically depend on membrane structure, such as
trafficking and sorting needed for normal caveolas assembling and,
ultimately, the localization of Cav-1 into apical membranes. Anyway,
we cannot rule out that lipid composition of preeclamptic Golgi may
be affected which, in turn, could affect membrane structure and/or lo-
calization of proteins that are required for transport carrier biogenesis.
This interesting issue will be the focus of further investigations.
In conclusion,we speculate that the increase of long andunsaturated
SM molecular specie found in MVM-vesicles from preeclamptic
placentas may disrupt the ability of SM to assemble into lipid rafts in
the luminal leaflet of the bilayer, creating an unfavorable environment
for appropriated location of Cav-1. Considering the important role
Cav-1 has in biological processes, our findings open a new insight in
the study of preeclampsia.Declaration of interest
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